What is the name of this mRNA vaccine? In September 2021, Gennova had issued a press statement, providing an update about the Covid-19 vaccine trials.
The pharmaceuticals firm had said the DCGI had approved in August that year the phase II and phase III study protocols for India's first mRNA-based Covid-19 vaccine, developed by Gennova Biopharmaceuticals Limited.
The name of the vaccine is HGCO19, it said, adding that Gennova had submitted the interim clinical data of the phase I study to the Central Drugs Standard Control Organisation (CDSCO), India's national regulatory authority.Never miss a story!